Catalyst Wire Dossier Catalyst Wire Dossier

BUPROPION HYDROCHLORIDE XL

BUPROPION HYDROCHLORIDE · Oryza pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

37 regulatory and trial events tracked for BUPROPION HYDROCHLORIDE XL, covering 2007-06-13 to 2026-08-19. Get the full timeline:

Most recent: FDA Approved: BUPROPION HYDROCHLORIDE (XL) — Supplemental Application (Exelan Pharmaceuticals Inc.)

See pricing